We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$25.5B
AUM Growth
-$11.1B
(-30%)
Cap. Flow
-$5.25B
Cap. Flow
% of AUM
-20.57%
Top 10 Holdings %
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.44% |
| 2 | Technology | 14.21% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 9.72% |
| 5 | Financials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
2351
DELISTED
Enzo Biochem, Inc.
ENZ
| $349K | ﹤0.01% |
125,562
+17,823
| +17% | +$58.4K |
|
2352
PUT
United Therapeutics
UTHR
$22B
| $348K | ﹤0.01% |
3,200
-2,800
| -47% | -$325K |
|
|
GTLS
2353
DELISTED
Chart Industries
GTLS
| $347K | ﹤0.01% |
5,330
-34,067
| -86% | -$2.25M |
|
2354
PUT
Intercontinental Exchange
ICE
$84.1B
| $347K | ﹤0.01% |
+4,600
| New | +$353K |
|
2355
Icon
ICLR
$12.6B
| $347K | ﹤0.01% |
+2,682
| New | +$370K |
|
2356
CALL
TAL Education Group
TAL
$6.71B
| $347K | ﹤0.01% |
13,000
-23,100
| -64% | -$613K |
|
|
GOL
2357
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $347K | ﹤0.01% |
+25,615
| New | +$259K |
|
|
ARR
2358
Armour Residential REIT
ARR
$2.35B
| $346K | ﹤0.01% |
3,379
-14,259
| -81% | -$1.54M |
|
2359
PUT
Centene
CNC
$33.1B
| $346K | ﹤0.01% |
+6,000
| New | +$402K |
|
2360
CALL
Olin
OLN
$2.13B
| $346K | ﹤0.01% |
17,200
+9,200
| +115% | +$196K |
|
|
CO
2361
DELISTED
Global Cord Blood Corporation
CO
| $346K | ﹤0.01% |
53,632
-32,763
| -38% | -$209K |
|
2362
Celldex Therapeutics
CLDX
$3.22B
| $345K | ﹤0.01% |
116,072
+1,724
| +2% | +$8.47K |
|
|
ACGN
2363
DELISTED
Aceragen Inc
ACGN
| $345K | ﹤0.01% |
7,337
+6,482
| +758% | +$745K |
|
2364
CALL
Home Depot
HD
$352B
| $344K | ﹤0.01% |
2,000
-56,800
| -97% | -$10.2M |
|
|
STKL
2365
DELISTED
SunOpta
STKL
| $344K | ﹤0.01% |
+88,941
| New | +$506K |
|
2366
The RMR Group
RMR
$324M
| $343K | ﹤0.01% |
6,458
+3,469
| +116% | +$245K |
|
2367
Ceco Environmental
CECO
$4.04B
| $342K | ﹤0.01% |
50,628
-54,333
| -52% | -$416K |
|
2368
Stellus Capital Investment Corp
SCM
$234M
| $341K | ﹤0.01% |
26,334
+5,708
| +28% | +$74.4K |
|
|
DERM
2369
DELISTED
Dermira, Inc.
DERM
| $340K | ﹤0.01% |
47,261
-247,394
| -84% | -$2.71M |
|
2370
PUT
Camping World
CWH
$670M
| $338K | ﹤0.01% |
29,500
+12,900
| +78% | +$229K |
|
2371
CALL
Dillards
DDS
$9.63B
| $338K | ﹤0.01% |
5,600
-9,000
| -62% | -$619K |
|
2372
Pixelworks
PXLW
$40.6M
| $338K | ﹤0.01% |
+9,714
| New | +$452K |
|
|
NXTM
2373
DELISTED
NxStage Medical Inc.
NXTM
| $338K | ﹤0.01% |
11,796
-4,219
| -26% | -$120K |
|
2374
CALL
Agilent Technologies
A
$39.9B
| $337K | ﹤0.01% |
5,000
-6,800
| -58% | -$457K |
|
2375
Assembly Biosciences
ASMB
$526M
| $336K | ﹤0.01% |
+1,238
| New | +$358K |
|
Similar funds
VAM
Two Sigma Investments's Q4 2018 Portfolio in Review
As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.
- Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
- Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.